Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial

British Journal of Anaesthesia

Volumn 119, Issue 3, 2017, Pages 411-421

  Collins, P W ^a   Cannings John, R ^a   Bruynseels, D ^b   Mallaiah, S ^c   Dick, J ^d   Elton, C ^e   Weeks, A D ^f   Sanders, J ^a   Aawar, N ^a   Townson, J ^a   Hood, K ^a   Hall, J E ^a   Collis, R E ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^c LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e LEICESTER ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

fibrinogen; postpartum haemorrhage; viscoelastometry

Indexed keywords

FIBRINOGEN CONCENTRATE; PLACEBO; FIBRINOGEN;

ADULT; CLINICAL OUTCOME; CONFERENCE PAPER; CONTROLLED STUDY; CRYOPRECIPITATE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PLASMA; POSTPARTUM HEMORRHAGE; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; TRANSFUSION; VISCOELASTOMETRY; CLINICAL TRIAL; MIDDLE AGED; PROCEDURES; THROMBOELASTOGRAPHY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; DOUBLE-BLIND METHOD; FEMALE; FIBRINOGEN; HUMANS; MIDDLE AGED; POSTPARTUM HEMORRHAGE; THROMBELASTOGRAPHY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85029815564     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aex181     Document Type: Conference Paper

References (34)

1. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2: e323-33
2. World Health Organisation. Maternal mortality: fact sheet 348. Available from http://www.who.int/mediacentre/fact sheets/fs348/en/(accessed 5 July 2017)
3. Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol 2013; 209: 449
4. Lennox C, Marr L. Scottish confidential audit of severe maternal morbidity: reducing avoidable harm 10th annual Report. Available from http://healthcareimprovementscot land.org/his/idoc.ashx?docid5fb640e2-d079-48cc-ad49-a5 8f6929b685&version-1. 2014 (accessed 5 July 2017)
5. Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. Br J Obstet Gynaecol 2012; 119: 1150-1
6. Novikova N, Hofmeyr GL. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2010; CD007872
7. Allard S, Green L, Hunt BJ. How we manage the haematologi-cal aspects of major obstetric haemorrhage. Br J Haematol 2014; 164: 177-88
8. Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia 2015; 70: 78-86
9. O'Riordan MN, Higgins JR. Haemostasis innormal and abnormal pregnancy. Best Pract Res 2003; 17: 385-96
10. Liu X, Jiang Y, Shi H, et al. Prospective, sequential, longitudinal study of coagulation changes during pregnancy in Chinese women. Int J Gynecol Obstet 2009; 105: 240-3
11. Szecsi PB, Jorgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010; 103: 718-27
12. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibri-nogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73
13. De Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20: 135-41
14. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014; 124: 1727-36
15. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108: 984-9
16. De Lloyd L, Collins PW, Kaye A, Collis RE. Early fibrinogen as a predictor of red cell requirements during postpartum haemorrhage. Int J Obstet Anesth 2012; 21: S13
17. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 2011; 37: 1816-25
18. National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoe-lastometric point-of-care testing (Rotem, TEG and Sonoclot systems). Availble from https://www.nice.org.uk/guidelines/gd13. 2016 (accessed 5 July 2017)
19. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombe-lastometry. BJOG 2009; 116: 1097-102
20. Aawar N, Alikhan R, Bruynseels D, et al. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: Study protocol for a randomised controlled trial. Trials 2015; 16:169
21. Lilley G, Burkitt St Laurent D, Precious E, et al. Measurement of blood loss during postpartum haemorrhage. Int J Obstet Anesth 2015; 24: 8-14
22. Bruynseels D, Solomon C, Haloi K, et al. Commentary on reconstituting fibrinogen concentrate to maintain blinding in a double-blind, randomised trial in an emergency setting. J Emerg Med 2016; 50: 104-7.e1
23. Wikkelsoe AJ, Edwards HM, Afshari A, et al. Pre-emptive treatment with fibrinogen concentrate for postpartum hae-morrhage: randomized controlled trial. Br J Anaesth 2015; 114: 623-33
24. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015; 70: 166-75
25. Mallaiah S, Chevannes C, McNamara H, Barclay P. A reply. Anaesthesia 2015; 70: 760-1
26. Hunt BJ, Allard S, Keeling D, et al. A practical guideline for the haematological management of major haemorrhage. Br J Haematol 2015; 170: 788-803
27. Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016; 71: 829-42
28. Collins PW, Kadir R, Thachil J. Management of coagulopathy associated with postpartum haemorrhage: guidance from the SSC of ISTH. J Thromb Haemost 2016; 14: 205-10
29. Karlsson O, Jeppsson A, Thornemo M, Lafrenz H, Ra°dström M, Hellgren M. Fibrinogen concentration before delivery is not associated with postpartum haemorrhage: a prospective observational study. Br J Anaesth 2015; 115: 94-104
30. Green L, Knight M, Seeney F, et al. The haematological management and transfusion requirements of women who required massive transfusion for major obstetric haemorrhage in the UK: a population based descriptive study. Br J Haematol 2016; 172: 616-24
31. Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coag-ulation and amniotic fluid embolism). Thromb Res 2013; 131: S32-4
32. Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009; 23: 167-76
33. Shields LE, Smalarz K, Reffigee L, et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol 2011; 205: 368
34. Shields LE, Wiesner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. Am J Obstet Gynecol 2015; 212: 272-80